Concord Healthcare Group Co., Ltd. (Stock code: 2453) has released an announcement detailing the newly established Remuneration and Appraisal Committee under its Board of Directors. According to the announcement, the Committee’s primary responsibilities include setting remuneration policies for directors and senior management, formulating and reviewing standards for performance appraisals, and ensuring a transparent basis for compensation decisions. The Committee will also provide recommendations to the Board while monitoring the implementation of relevant remuneration structures, payment plans, and performance evaluations.

The announcement specifies that the Committee must consist of at least three directors, with the majority being independent non-executive directors. A chairman (convener), who must also be an independent non-executive director, will lead the Committee. The document outlines meeting arrangements, voting details, and confidentiality requirements, ensuring that decisions on remuneration and performance appraisals align with legal regulations, the Articles of Association, and the listing rules of The Stock Exchange of Hong Kong Limited.